Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents

Farmaco

Volumn 60, Issue 4, 2005, Pages 283-290

  Jindal, Dharam Paul ^a   Bedi, Vikas ^a   Jit, Birinder ^a   Karkra, Nalin ^a   Guleria, Sheetal ^a   Bansal, Ranju ^a   Palusczak, Anja ^b   Hartmann, Rolf W ^b  

^a PANJAB UNIVERSITY   (India)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

60 cell line; Aminoglutethimide; Anticancer agents; Aromatase; N imide derivatives

Indexed keywords

3 (4 AMINOPHENYL) 1 (DIMETHYLAMINOETHYL) 3 ETHYLPIPERIDINE 2,6 DIONE; 3 (4 AMINOPHENYL) 3 ETHYL 1 (2 MORPHOLIN 4 YLETHYL)PIPERIDINE 2,6 DIONE; 3 (4 AMINOPHENYL) 3 ETHYL 1 (2 PYRROLIDIN 1 YLETHYL)PIPERIDINE 2,6 DIONE; 3 [4 (3 NITRO 1,8 NAPHTHALIMIDO)PHENYL] 3 ETHYL 2,6 PIPERIDINEDIONE; 3 [4 (4,5 DIMETHOXYPHTHALIMIDO)PHENYL] 3 ETHYL 2,6 PIPERIDINEDIONE; 3 [4 (PHTHALIMIDO)PHENYL] 3 ETHYL 2,6 PIPERIDINEDIONE; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENT; AROMATASE; DOXORUBICIN; FLUOROURACIL; IMIDE; N (4,5 DIHYDRO 1H IMIDAZOL 2 YLAMINO) 1,8 NAPHTHALIMIDE; N (4,5 DIHYDRO 1H IMIDAZOL 2 YLAMINO) 5,6 DIMETHOXYPHTHALIMIDE; N (4,5 DIHYDRO 1H IMIDAZOL 2 YLAMINO)PHTHALIMIDE; N [4 (2 N,N DIETHYLAMINOETHOXY)PHENYL] 3 NITRO 1,8 NAPHTHALIMIDE; N [4 (2 PIPERIDINOETHOXY)PHENYL] 3 AMINO 1,8 NAPHTHALIMIDE; N [4 (2 PYRROLIDINOETHOXY)PHENYL] 3 NITRO 1,8 NAPHTHALIMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; SUBSTITUTION REACTION;

EID: 17444370491     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.01.011     Document Type: Article

References (28)

1. M.F. Brana, M. Cacho, A. Gradillas, B. de Pascual-Teresa, and A. Ramos Intercalators as anticancer drugs Curr. Pharm. Des. 17 2001 1745 1780
2. F.A. Tanious, T.C. Jenkins, S. Neidle, and W.D. Wilson Substituent position dictates the intercalative DNA-binding mode for anthracene-9,10-dione antitumor drugs Biochemistry 31 1992 11632 11640
3. P.S. Callery, and P.M. Gannett Cancer and Cancer Chemotherapy D.A. Williams T.L. Lemke Foye's Principles of Medicinal Chemistry 5th ed. 2002 Lippincott Williams and Wilkins Philadelphia 924 952
4. S.W. Hall, J. Freidman, S.S. Legha, R.S. Benjamin, J.V. Gutterman, and T.L. Loo Human pharmacokinetics of a new acridine derivative, 4′-(9-acridinylamino) methanesulfon-m-anisidide (NSC 249992) Cancer Res. 43 1983 3422 3426
5. A. Goldin, M.M. Venditti, J.S. McDonald, F.M. Muggia, J.E. Henney, and V.T. Devita Current results of the screening program at the division of cancer treatment, National Cancer Institute Eur. J. Cancer 17 1981 129 141
6. S.A. Gamage, J.A. Spicer, G.J. Atwell, G.J. Finlay, B.C. Baguley, and W.A. Denny Structure-activity relationships for substituted bis(acridine-4- carboxamides): a new class of anticancer agents J. Med. Chem. 42 1999 2383 2393
7. G.W. Rewcastle, W.A. Denny, and B.C. Baguley Potential antitumor agents. 51. Synthesis & antitumor activity of substituted phenazine-1-carboxamides J. Med. Chem. 30 1987 843 851
8. M. Yamato, Y. Takeuchi, M. Chang, K. Hashigaki, T. Tsuruo, and T. Tashiro Synthesis and antitumor activity of fused quinoline derivatives Chem. Pharm. Bull. (Tokyo) 38 1990 3048 3052
9. G.J. Atwell, B.C. Baguley, and W.A. Denny Potential antitumor agents. 55. 6-Phenylphenan- thridine-4-carboxamides: a new class of DNA-intercalating antitumor agents J. Med. Chem. 31 1988 774 779
10. H.D.H. Showalter, J.L. Johnson, J.M. Hoftiezer, W.R. Turner, L.M. Werbel, and W.R. Leopold Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias J. Med. Chem. 30 1987 121 131
11. J.M. Herbert, P.D. Woodgate, and W.A. Denny Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents J. Med. Chem. 30 1987 2081 2086
12. B.S. Iyengar, R.T. Dorr, D.S. Alberts, A.M. Solyom, and W.A. Remers 1,4-Disubstituted anthracene antitumor agents J. Med. Chem. 40 1997 3734 3738
13. R.K.Y. Zee-Cheng, and C.C. Cheng N-(Aminoalkyl)imide antineoplastic agents. Synthesis and biological activity J. Med. Chem. 28 1985 1216 1222
14. S.M. Sami, R.T. Dorr, D.S. Alberts, and W.A. Remers 2-Substituted 1,2-dihydro-3H-dibenz-[de,h] isoquinoline-1,3-diones. A novel class of antitumor agent J. Med. Chem. 36 1993 765 770
15. S.M. Sami, R.T. Dorr, D.S. Alberts, A.M. Solyom, and W.A. Remers 2-[2′-(Dimethylamino) ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3- diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity and quantitative structure-activity relationships J. Med. Chem. 39 1996 4978 4987
16. M.F. Brana, J.M. Castellano, M. Moran, F. Emling, M. Kluge, and E. Schlick Walker, Synthesis, structure and antitumor activity of new Benz [de]isoquinoline-1,3-diones, Arzneim.- Forsch. 45 1995 1311 1318
17. M.P. Costi, D. Tondi, M. Rinaldi, D. Barlocco, G. Cignarella, and D.V. Santi Naphthalimido derivatives as antifolate thymidylate synthase inhibitors J. Med. Chem. 31 1996 1011 1016
18. G. Cocconi First generation aromatase inhibitors-aminoglutethimide and testololactone Breast Cancer Res. Treat. 30 1994 57 80
19. A.S. Bhatnagar, A.M.H. Brodie, B.J. Long, D.B. Evans, and W.R. Miller Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors J. Steroid Biochem. Mol. Biol. 76 2001 199 202
20. M. Clemons, S. Danson, and A. Howell Tamoxifen ('Nolvadex'): a review Cancer Treat. Rev. 28 2002 165 180
21. G.-E. Seraloni, and S. Moslemi Aromatase inhibitors: past, present and future Mol. Cell. Endocrinol. 178 2001 117 131
22. T. Wada, H. Koyama, and T. Terasawa Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydro furyl)-5-fluorouracil in the treatment of advanced breast cancer Breast Cancer Res. Treat. 1 1981 53 58
23. D.P. Jindal, R. Chattopadhaya, S. Guleria, and R. Gupta Synthesis and antineoplastic activity of 2-alkylaminoethyl derivatives of various steroidal oximes Eur. J. Med. Chem. 38 2003 1025 1034
24. R. Chattopadhaya, D.P. Jindal, M. Minu, and R. Gupta Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids Arzneim. Forsch. 54 2004 551 556
25. M.R. Boyd, and K.D. Paull Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen Drug Dev. Res. 34 1995 91 109
26. E.A. Thompson, and P.K. Siiteri Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione J. Biol. Chem. 249 1974 5364 5372
27. A.B. Foster, M. Jarman, C.S. Leung, M.G. Rowlands, and G.N. Taylor Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage J. Med. Chem. 26 1983 50 54
28. P.E. Graves, and H.A. Salhanick Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide Endocrinology 105 1979 52 57